Company
ALKemist BIO
Reprogramming Immunity to Rewrite the Future of ALK+ Cancer Care
Also known as ALKemist Bio S.r.l.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Turin, TO, Italy
- Legal name
- ALKemist Bio S.r.l.
Record updated 28 September 2026
About
At ALKemist Bio, we are developing novel immuno-therapies specifically designed to recognize the ALK oncogene—a known driver of several aggressive and treatment-resistant cancers.
Funding snapshot
- Latest round
- Undisclosed2023-12-21
Funding rounds
- Investment Round
- 2023-12-21